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Summary
Lipid droplets (LDs) are dynamic organelles that collect,
store, and supply lipids [1]. LDs have a central role in the
exchange of lipids occurring between the cell and the
environment and provide cells with substrates for energy
metabolism, membrane synthesis, and production of lipid-
derived molecules such as lipoproteins or hormones.
However, lipid-derived metabolites also cause progressive
lipotoxicity [2], accumulation of reactive oxygen species
(ROS), endoplasmic reticulum stress, mitochondrial mal-
functioning, and cell death [2]. Intracellular accumulation
of LDs is a hallmark of prevalent human diseases, including
obesity, steatosis, diabetes, myopathies, and arterioscle-
rosis [3]. Indeed, nonalcoholic fatty liver disease is the
most common cause of abnormal hepatic function among
adults [4, 5]. Lipotoxicity gradually promotes cellular
ballooning and disarray, megamitochondria, accumulation
of Mallory’s hyaline in hepatocytes, and inflammation,
fibrosis, and cirrhosis in the liver. Here, using confocal
microscopy, serial-block-face scanning electron micro-
scopy, and flow cytometry, we show that LD accumulation
is heterogeneous within a cell population and follows a
positive skewed distribution. Lipid availability and fluctua-
tions in biochemical networks controlling lipolysis, fatty
acid oxidation, and protein synthesis contribute to cell-to-
cell heterogeneity. Critically, this reversible variability
generates a subpopulation of cells that effectively collect
and store lipids. This high-lipid subpopulation accu-
mulates more LDs and more ROS and reduces the risk of
lipotoxicity to the population without impairing overall lipid*Correspondence: apols@ub.eduhomeostasis, since high-lipid cells can supply stored lipids
to the other cells. In conclusion, we demonstrate fat storage
compartmentalization within a cell population and pro-
pose that this is a protective social organization to reduce
lipotoxicity.
Results and Discussion
LD Accumulation Is Cell-to-Cell Heterogeneous
The liver is essential for the body’s fat metabolism by storing
and processing lipids and is thus persistently threatened by
lipotoxicity. Although they are poorly understood, there are
likely to be cellular mechanisms to simultaneously deal with
the beneficial and harmful aspects of intracellular lipids.
Here, to investigate whether such mechanisms exist in
hepatic cells, we first examined lipid droplet (LD) distribution
in mice liver sections. In control livers, there were relatively
few LDs (Figure 1A). However, some hepatocytes clearly
accumulated LDs (black globular structures, red arrows),
whereas others completely lacked LDs (green arrows). Under
starvation or after a partial hepatectomy, LDs accumulated
(white globular structures, Figures 1B–1D). In both cases,
cell-to-cell differences in LD size and number were evident,
and the highest variability occurred 48 hr after hepatectomy.
To further characterize the heterogeneous LD accumulation
of untreated livers, we used a new technique, serial-block-
face scanning electron microscopy (3View). LDs were clearly
distinguished by their electron density (Figure 1E). The anal-
ysis of 1,000 consecutive sections (approximately 50 mm
depth) revealed the presence of LDs in all hepatocytes and
demonstrated high variability between them (Movie S1 avail-
able online). As an example of cell-to-cell heterogeneity, we
selected two neighboring hepatocytes for a detailed segmen-
tation analysis (Figure 1E, Movie S2, and Movie S3). The com-
parison of the volumetric occupancy of LDs demonstrated
striking differences; 10.9% (97.7 mm3) of the cytoplasmic vol-
ume of cell 1 was occupied by LDs, whereas only 2.6%
(27.6 mm3) of the volume of cell 2 was occupied by LDs (Figures
1F and 1G).
For analysis of whether cell-to-cell heterogeneity reflects
the zonal distribution of hepatocytes within the liver, primary
hepatocytes were isolated, labeled with Nile Red, and
analyzed by microscopy. Only some of these hepatocytes
accumulated LDs (left panel, Figure 1H). When these hepato-
cytes were identically treated for 24 hr with fatty acids (FAs;
albumin-bound oleate), all accumulated LDs but a high hetero-
geneity in LD number and size was observed (right panel,
Figure 1H). Therefore, although liver architecture is a likely
source of some variability, heterogeneity seems to be essen-
tially regulated by intracellular factors.
Extent of Heterogeneity in LD Content
LD accumulation has traditionally been studied in adipocytes,
where cell-to-cell differences have been reported during
progression of adipogenesis [6]. Variability has also been
occasionally mentioned when LDs were promoted under labo-
ratory conditions in clonal yeast, fibroblasts, and tumor cell
lines [7–9]. Histological scoring of steatotic livers has also
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Figure 1. Hepatic LD Heterogeneity
(A–D) Control (A), starved (B), and 24 hr (C) and 48 hr (D) after partial hepatectomy mouse liver sections stained with methylene blue. LDs are the black (A) or
white (B–D) rounded organelles. Red and green arrows indicate cells with high- or low-lipid content. Scale bars represent 50 mm.
(E–G) 3Viewmicroscopy of control mice liver. Representative stacks show the two selected cells (black lines, E) and segmentation analysis of cell 1 (F) or cell
2 (G). Translucent white lines, plasma membrane; light blue, nuclei; yellow, lipid droplets.
(H and I) Primary hepatocytes (H) and AML12 cells (I) in standardmedia (left) or loaded for 24 hr with FAs (50 mg/ml for hepatocytes and 175 mg/ml for AML12,
right), stained with Nile Red (LDs, red) and Hoechst (nucleus, blue). Red and green arrows indicate cells with high- or low-lipid content. Scale bars repre-
sent 10 mm.
(legend continued on next page)
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1491revealed hepatocyte-to-hepatocyte heterogeneity in human
biopsies [10]. However, such variability has been masked by
commonly used experimental techniques, and the degree,
sources, and potential utility of cell-to-cell heterogeneity
have received little attention.
To quantify LD accumulation cell by cell, we used flow
cytometry. Starting from previous protocols [8], we optimized
the approach to measure the LD content of individual cells.
Due to cellular aggregation, this method was not reliable for
primary hepatocytes, so instead we analyzed AML12 cells
(alpha mouse liver 12) [11]. Microscopy analysis demon-
strated that AML12 also exhibited high heterogeneity before
and after the loading with FAs (Figure 1I). For quantification
of these differences, AML12 cells were loaded with FAs and
labeled with Nile Red, and neutral lipid accumulation by indi-
vidual cells was determined via flow cytometry in 1 3 104
cells per experiment. As expected, FA treatment increased
the average LD content (red line, Figure 1J), and it was
reduced with Triacsin C (blue line, Figure 1J), a potent inhib-
itor of LD formation (Figure S1A and the Supplemental
Results and Discussion). The relative increment measured
by flow cytometry was identical to the result obtained with
an enzymatic method (Figure S1A and the Supplemental
Results and Discussion).
The histograms and dot plots demonstrated a high hetero-
geneity in the cellular LD content (Figures 1J and 1K), with
approximately 100-fold maximal cell-to-cell differences in LD
levels. To measure heterogeneity, we calculated the percent
robust coefficient of variation (%rCV), defined as %rCV =
[(rSD / median) 3 100]. Intuitively, the %rCV measures the
average deviation of an individual cell from the population
median. In FA-loaded cells, the overall %rCV was 57% 6 9%
(Figure 1L), although the most loaded 15% of the hepatocytes
(arbitrary cutoff, see Figure 4 below) showed an average%rCV
with respect the whole population median of 205% 6 30%. In
contrast, the standard deviation between %rCV of indepen-
dent experiments was only 9%, suggesting that overall the
%rCV is relatively constant. When compared with other cell
lines, heterogeneity was particularly high in hepatic cells (Fig-
ure S1B). Thus, the extent of heterogeneity is different
between different cell types, suggesting that it is potentially
controllable.
Causes of Heterogeneity in LD Content
Next, we analyzed how environmental and intracellular factors
determine heterogeneity (Figure 2A). To assess how lipid avail-
ability contributes to heterogeneity, we incubated AML12 cells
for 24 hr with increasing FA doses. As expected, overall LD
accumulation was proportional to lipid availability (Figures
2B and 2C). The %rCV was maximal at low concentrations
and progressively decreased with higher doses (Figure 2D).
Linear histograms reveal that with moderate concentrations
of FAs (up to 250 mg/ml), the LD content of the population
followed a positive skewed distribution, suggesting possible
collective mechanisms to increase themass of the distribution
in low-lipid cells, by preferential accumulation of lipids in
a reduced number of high-lipid cells (Figure 2B). In contrast,
higher doses of FAs progressively decreased asymmetry (as(J–L) Representative histogram (linear scale, J) of Nile Red fluorescence of cont
with FA and 10 mMTriacsin C (‘‘Loaded+TRC,’’ blue). Representative dot plots (l
nonloaded (left) and loaded cells (right) are shown (K).%rCV of Nile Red fluoresc
SEM in at least ten independent experiments.
See also Figure S1, Movie S1, Movie S2, and Movie S3.measured by skewness, Figure 2E), the relative percentage
of cells in the low lipid range, and thus the final %rCV.
We also analyzed whether LD unloading contributes to
heterogeneity. Thus, FA-loaded cells were subsequently incu-
bated in a FA-free media for 16 hr. As expected, the LD levels
were reduced, but interestingly the %rCV increased sig-
nificantly (white bars, Figures 2F and 2I). Importantly, LD
unloading and heterogeneity were highly reduced by relatively
low concentrations of FAs in the media. Thus, systems with
prolonged circulating lipids—e.g., obese individuals—will not
only increase LD formation but also reduce LD unloading
and heterogeneity.
We next used specific inhibitors of intracellular processes
related to LD accumulation to determine the pathways that
contribute to heterogeneity (Figure 2A and the Supplemental
Results and Discussion). Inhibition of lipases (diethylumbelli-
feryl phosphate [DEUP]) or mitochondrial FA uptake (etomoxir
[ETO]) increased the LD content and reduced cell-to-cell
heterogeneity (Figures 2G, 2J, and S2). In contrast, inhibition
of protein translation (cycloheximide [CHX]) reduced both
the LD content and heterogeneity, pinpointing differences in
the FA-promoted protein synthesis as an important source of
variability. Inhibition of autophagy (3-methyl-adenine [3MA])
slightly decreased LD levels and the %rCV, suggesting that
under these conditions LDs are not significantly metabolized
by this mechanism but are supplied with lipids from auto-
phagy. Other factors such as the phase of the cell cycle and
the synthesis of new FAs did not affect heterogeneity (Fig-
ure S2 and the Supplemental Results and Discussion).
To evaluate heterogeneity sources during unloading, we
incubated previously FA-loaded cells for 16 hr in FA-freemedia
but in the presence of the inhibitors. The unloading of LDs was
now highly reduced when lipolysis (DEUP) and autophagy
(3MA) were inhibited, suggesting that LD unloading is con-
ducted by both mechanisms (Figures 2H and 2K). Inhibition
of mitochondrial FA uptake (ETO) and protein synthesis
(CHX) also reduced LD unloading. The inhibition of lipases
or mitochondrial FA uptake decreased heterogeneity. In
contrast, inhibition of protein synthesis or autophagy had no
effect on the %rCV, suggesting that these mechanisms are
activated proportionally to the LD content of each cell. Thus,
LD storage and heterogeneity are overall regulated by lipid
availability, although they are also determined by the oxidation
of FAs, lipolysis, and the synthesis of new protein.
Heterogeneity in LD Content Is Regulated by Reversible
Mechanisms
Phenotypic heterogeneity within a cell population is well
known yet poorly understood. When identical cells—or the
same cell over time—respond differently to an identical
stimulus, it is often caused by stochasticity in gene expres-
sion, which can reflect fluctuations of transcription and/or
translation of genes and proteins [12]. In principle, stochas-
ticity provides a mechanism for different cells in an identical
population to sample different physiological states without
need for irreversible genetic mutations, making it likely that
at least some of the population survives/functions when faced
with different types of unexpected challenges.rol cells (‘‘Non-loaded,’’ black), cells loaded with FA (‘‘Loaded,’’ red), or cells
ogarithmic scale) of Nile Red fluorescence versus forward scatter (FCS-H) in
ence of nonloaded and loaded cells is shown (L). Data represent themean6
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Figure 2. Causes of LD Heterogeneity
(A) Biochemical networks (black) and interfering drugs (color arrows) related to LD metabolism (PL, phospholipid; Mito, mitochondria; ER, endoplasmic
reticulum; autoph, autophagosome).
(B–E) Quantification of LD content and heterogeneity of AML12 cells treated 24 hr with the indicated doses of FAs. Representative histograms (linear scale,
B), average LD accumulation compared to nonloaded cells (C), %rCV (D), and skewness coefficient (E) of the distributions are shown.
(legend continued on next page)
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1493Thus, we analyzed whether the heterogeneity is reversible,
as expected from stochastic biochemical networks. After FA
loading, the high- and low-lipid-loaded cells of the population
were separated by flow cytometry using side scatter (SSC-A)
as the sorting criteria. This SSC-A reflects the cell’s inner
complexity and is proportional to LD levels (Figure 3A and
the Supplemental Results and Discussion) [13]. With this
method, the separated high-lipid cells had double the lipid
content of the low-lipid cells (Figures 3B and 3C). Next, both
subpopulations were independently recultured during 7 days
in standard media to metabolize LDs, eliminating the majority
of LDs (Figure 3D, ‘‘7 days’’). Finally, cells were again FA
loaded, and the LD content was quantified. At an overall pop-
ulation level, the original high- and low-lipid cells were indistin-
guishable and accumulated equivalent LDs (Figure 3D,
‘‘7 days + 24h FA’’). Importantly, the %rCV was identical for
each group of newly cultured cells that had originated from
different subpopulations and was identical to the %rCV of
the whole population before sorting (Figure 3E). Thus, as
expected from a process regulated by stochasticity, the cell’s
capacity to accumulate LDs heterogeneously is variable and
reversible over time. It is likely, then, that this reversibility
allows exchange of the risk of lipotoxicity between different
cells of the population over time.
High-Lipid Cells Are an Advantage for the Population
The existence of cells specialized in fat storage is conserved
from flies to humans, suggesting that fat compartmentaliza-
tion has been a positive trait during evolution. In worms, in
the absence of an authentic adipose tissue, C. elegans com-
partmentalizes the fat in the intestine [14]. Further, we have
confirmed (data not shown) the existence of a high heteroge-
neity in clonal populations of unicellular organisms such as
the yeast Saccharomyces cerevisiae [7]. In humans, when
such compartmentalization is impaired, a series of complex
metabolic effects (commonly known as lipodystrophies) is
elicited in the rest of cells [15]. Lipodystrophies are associ-
ated with early multi-organ complications especially in
cardiovascular and hepatic tissues that lead to diabetes
and metabolic syndromes [3]. Therefore, similar to adipose
tissue, we hypothesized that the existence of high-lipid
cells within a cell population might potentially reduce lipo-
toxicity to the average cell without impairing overall lipid
homeostasis.
To explore the cell-to-cell distribution of toxic metabolites,
we first separated the cells into high- and low-lipid subpopula-
tions by flow cytometry and measured reactive oxygen
species (ROS) levels in each subpopulation. ROS levels were
higher in high-lipid cells (Figure 3F). Importantly, cell-to-cell
correlation studies on the whole population demonstrated
that ROS levels were proportional to LD levels (Figure 3G).
Single-cell analysis demonstrated that the 15% of cells with
the highest LD levels (arbitrary cutoff) accumulate much
more than 15% of the overall lipids and also have 53% more
ROS than themean of the population (distribution in Figure 3G,
left, and averages of ROS for each group of cells shown in(F and I) FA-loaded cells were incubated for additional 16 hr in a FA-free me
compared to loaded cells (red bar) and the %rCV (I) were calculated. Statistic
(G and J) LD accumulation (G) and %rCV (J) of nonloaded cells and cells load
(ETO), or 10 mg/ml cycloheximide (CHX). Statistical significance was calculate
(H and K) LD accumulation (H) and %rCV (K) of nonloaded cells, loaded cells
detailed in (G). Statistical significance was calculated versus unloaded cells (w
Data represent mean 6 SEM in at least three independent experiments. See aFigure 3G, right). Thus, this small percentage of high-lipid cells
allows 40% of the population to have low lipids and a signifi-
cant reduction of ROS (nearly 30%), which was similar to the
ROS levels of these cells before the addition of FAs (data not
shown). These results suggest that LD compartmentalization
reduces toxic metabolites in most cells and thus is an advan-
tage for the population.
To directly test this idea of ROS protection due to high-lipid
cells, we created a set of initially low-lipid cells to act as ‘‘indi-
cator’’ cells. These cells, cultured in standard conditions, were
labeled with the fluorescent CellTrace DDAO-SE (far-red emis-
sion). The ‘‘indicator’’ cells were mixed with either (1) addi-
tional unlabeled low-lipid cells or (2) unlabeled high-lipid cells
generated by treatment with 500 mg/ml FAs for 24 hr (see Fig-
ures 2B–2E). Then, the mixed cell population was cocultured
for 16 hr in either normal media or in the presence of lipotoxic
palmitic acid. Finally, ROS levels were measured only in ‘‘indi-
cator’’ cells (Figure 4A) or in the whole population (Figure 4B).
Importantly, the ‘‘indicator’’ cells had less ROS when cocul-
tured with high-lipid cells (white bar in palmitic, Figure 4A)
than with low-lipid cells (black bar in Figure 4A), showing
that indeed the presence of the high-lipid cells can decrease
ROS in the low lipid cells. Surprisingly, the presence of high-
lipid cells was also protective during palmitic incubation for
the population as a whole, since total ROS levels were signifi-
cantly reduced when high-lipid cells were present in the cul-
ture (white bar in palmitic, Figure 4B). The beneficial effects
of high-lipid cells were also seen when cells were in standard
media (white bars in control, Figure 4B). Thus, high-lipid cells
protect not only low-lipid cells but, importantly, reduce ROS
levels to the entire population. On the basis of these findings,
we suggest that high-lipid cells activate systems to reduce
ROS accumulation, but these mechanisms will need to be
tested in future work.
The protective effect of the high-lipid cells could be indirect
(e.g., due to cell-cell communication between the two groups).
However, it could be also produced by local titration of FAs
from the media. This last possibility is likely, since the rate of
lipid uptake was directly proportional to the cellular levels of
LDs (Figure S3) and when cocultured, high-lipid cells take up
more lipids than ‘‘indicator’’ cells (Figure 4C). To test this pos-
sibility, we cocultured ‘‘indicator’’ cells with low- or high-lipid
cells for 16 hr in the presence of FAs and measured the result-
ing LD accumulation. The ‘‘indicator’’ cells accumulated fewer
LDs in the presence of high-lipid cells (Figure 4D), supporting
the hypothesis that high-lipid cells reduce accumulation of
LDs to low-lipid cells and may in this way decrease overall
lipotoxicity.
High-Lipid Cells Supply Lipids to the Population
The main function of an adipose tissue is first to collect and
store lipids when they are in excess and then, without impair-
ing overall lipid homeostasis, to provide these lipids to other
cells when lipid availability is compromised. Therefore, to test
the hypothesis that high-lipid cells are functioning—at a
cellular level—as an adipose tissue, we analyzed whetherdium containing the indicated concentrations of FAs. LD accumulation (F)
al significance was calculated versus unloaded control cells (white bars).
ed with FA in the presence of 500 mM DEUP, 10 mM 3MA, 100 mM etomoxir
d versus loaded cells (red bars).
, and cells additionally unloaded 16 hr in a FA-free medium and the drugs
hite bars).
lso Figure S2.
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(A) Correlation between Nile Red fluorescence and SSC-A in AML12 cells.
(B and C) Representative histogram (B) and mean LD content (C) of high- and low-lipid cells sorted by SSC-A and stained with Nile Red.
(D and E) LD accumulation (D) and %rCV (E) of cells sorted as in (B) and maintained for 7 days in normal medium and additionally treated for 24 hr with
175 mg/ml FA.
(F) ROS in sorted cells measured as DCF fluorescence compared to low-lipid cells.
(G) Representative dot plot of the SSC-A (LDs) versus DCF fluorescence (ROS) in the whole population of cells. Cells are classified (arbitrary cutoff) in low-
(40.4% of the population), medium- (43.4%), or high- (15.4%) lipid cells. Mean DCF fluorescence in each type of cells compared to mean of the population is
shown. Statistical significance was calculated versus low cells (black bars).
Data represent the mean 6 SEM of at least four independent experiments.
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To visualize lipid exchange, we accumulated the BODIPY-FA
in the LDs of high-lipid cells (Figure S4 and the Supplemental
Results and Discussion). Then, these high-lipid cells were
cocultured with ‘‘indicator’’ cells for 16 hr, and the exchange
of lipids was measured by flow cytometry. Initially, ‘‘indi-
cator’’ and high-lipid cells were clearly distinguished by the
absence or presence of green fluorescence (red and black
lines in Figure 4E). However, 16 hr after coplating, the transfer
of the green FA was detected. The new curves (orange
for ‘‘indicator’’ cells and green for high-lipid cells) were
between the original curves. Thus, ‘‘indicator’’ cells accumu-
lated fluorescent lipids and high-lipid cells with decreased
lipids had become a donor population. The exchange was
confirmed by fluorescence microscopy (Figure 4F). Although
the cellular mechanisms involved in lipid exchange will
require further analysis, the unloading of the fluorescent lipid
by high-lipid cells was higher in the presence of low-lipid
‘‘indicator’’ cells (white bar, Figure 4G) than in the presence
of other unlabelled high-lipid cells (black bar, Figure 4G),
suggesting possible mechanisms of cell-to-cell communica-
tion between the two groups and potentially the result of
increased lipids in the media due to release of FAs from all
of the high lipid cells.Concluding Remarks
Here, we show that cellular LD storage is overall regulated by
lipid availability but is also affected by cell-to-cell variable
biochemical networks. Indeed, when cells of a clonal popula-
tion are identically treated with extracellular lipids, the
accumulation of LDs follows a heterogeneous and skewed
distribution, with most cells having relatively low-lipid accu-
mulation and a few with high-lipid storage. As expected from
mechanisms regulated by reversible stochastic mechanisms,
high-lipid cells are an advantage for the population: when
facing toxic lipids or prolonged exposure to FAs, most
cells—and, intriguingly, the whole population—have fewer
toxic metabolites than would be expected for cells with that
average lipid accumulation. In addition, the high-lipid cells
can supply stored lipids to the low-lipid cells, effectively
functioning—at a cellular level—as adipose tissue.
Intriguingly, maximal heterogeneity and skewness occur at
relatively low overall levels of lipid availability, consistent
with the hypothesis that mechanisms of heterogeneity are
overwhelmedwhen exposed to excess lipids.When compared
with other cell lines, heterogeneity is particularly high in
hepatic cells, suggesting that this protectivemechanism could
be particularly important for the liver. This appears to have
direct implications for NAFLD, an increasingly important
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Figure 4. High-Lipid Cells Are Population Advantage
(A–D) Nonloaded AML12 cells were stained with CellTrace DDAO-SE (indicator cells) and mixed for 16 hr with nonloaded cells (‘‘Low,’’ black bars) or cells
loaded 24 hr with 500mg/ml of FA to generate high-lipid cells (‘‘High,’’ white bars). ROS levels (as in Figure 3F) in the indicator subpopulation (A) and thewhole
population (B) in cells treated 16 hr after mixing with control medium or supplemented with 50mg/ml palmitic acid are shown. Statistical significance was
calculated versus the indicator mixed with the low population (black bars). A representative histogram and mean FA uptake of indicator (red line) and
high-lipid cells (black line) cocultured 16 hr in control medium is shown (C). Statistical significance was calculated versus indicator cells. Analysis of LD
content in indicator cells cocultured with low-lipid (black bars) or high-lipid (white bars) cells incubated for 16 hr in control medium or in medium supple-
mented with 50mg/ml FA (oleic) is shown (D). Statistical significance was calculated versus the indicator mixed with the low population.
(E–G) Indicator cells were cocultured for 16 hr with high-lipid cells with a BODIPY-FA accumulated in LDs (‘‘High’’; see the Supplemental Results and
Discussion and Figure S4). Histogram of BODIPY-FA content analyzed in high-lipid cells and indicator cells before mixing (black and red lines, respectively)
and after mixing (green and orange lines, respectively) is shown (E). The mean fold increase 6 SEM of BODIPY-FA in indicator cells is indicated. Statistical
significance was calculated versus indicator cells before mixing (red line). The BODIPY-FA in the indicator cells, before and after mixing as in (E), was
analyzed by microscopy (F). BODIPY-FA fluorescence in high-lipid cells (loaded as in E) was measured after 16 hr with indicator (white bar) or high-lipid
(black bar) cells (G). Statistical significance was calculated versus the high-lipid population.
Data represent the mean 6 SEM of at least four independent experiments. See also Figures S3 and S4.
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1495chronic liver disease, because it is strongly correlated with
obesity and thus with a persistent lipid exposure [16]. Such a
prolonged lipid exposure will not only increase LD formation
but will also reduce LD unloading and heterogeneity. In addi-
tion, other intracellular heterogeneous factors, such as the
mitochondrial activity, also determine the LD content of indi-
vidual hepatocytes, pinpointing additional risk factors for
NAFLD development. Whether mechanisms of heterogeneity
in the liver are identical to the mechanisms detailed here for
hepatic cells or whether they are also determined by changes
in cell physiology due to zonal arrangement will require addi-
tional analysis. Importantly, genes and proteins contributing
to heterogeneity are likely to be rate-limiting steps within
each network and are thus a new set of targets to modulate
for potential clinical utility and also to better understand the
cellular basis and risk factors for developing NAFLD.Experimental Procedures
Reagents
Nile Red, BODIPY-FLC16, Hoechst-33258, CellTrace Far Red DDAO-SE,
and BODIPY 493/503 were from Molecular Probes, Invitrogen. Fatty-acid-
free BSA, collagenase type IV, 20,70-dichlorofluorescein diacetate
(H2DCFDA), palmitic acid, thymidine, DEUP, 3MA, platensimycin (PTM),
diethyl-p-nitrophenyl phosphate (E600), ETO, and CHX were purchased
from Sigma-Aldrich. Triacsin C (TRC) was from Santa Cruz Biotechnology.Oleic acid and mowiol were from Calbiochem. A detailed explanation of
the methods used in this manuscript can be found in the Supplemental
Experimental Procedures.
Statistical Analysis
All data shown in graphs are the mean and SEM, and the statistical
significance were determined with the Student’s t test (*p < 0.05, **p <
0.01, ***p < 0.001).
Supplemental Information
Supplemental Information includes Supplemental Results and Discussion,
Supplemental Experimental Procedures, four figures, and three movies
and can be found with this article online at http://dx.doi.org/10.1016/
j.cub.2013.06.032.
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